Category Archives: Mesenchymal Stem Cells

Miami, FL (PRWEB) May 31, 2014 Global Stem Cells Group, its subsidiary Stem Cell Training, Inc. and Bioheart, Inc. have announced plans to conduct a two-day, hands-on intensive stem cell training course at the Servet CordnVida Clinic Sept. 27 and 28 in Santiago, Chile. The Adipose Derived Harvesting, Isolation and Re-integration Training Course, will follow the Global Stem Cells Group First International Symposium on Stem Cells and Regenerative Medicine at the Santiago InterContinental Hotel Sept. 26, 2014. Global Stem Cells Group and the Servet CordnVida Stem Cell Bank Clinic of Chile are co-organizing the symposium, designed to initiate a dialogue between researchers and practitioners and share the expertise of some of the worlds leading experts on stem cell research and therapies. Servet CordnVida is a private umbilical cord blood bank that harvests and stores the hematopoietic-rich blood stem cells found in all newborns umbilical cords after birth. The hematopoietic tissue is responsible for the renewal of all components of the blood (hematopoiesis) and has the ability to regenerate bone marrow and restore depressed immune systems. Umbilical (UCB) stem cells offer a wealth of therapeutic potential because they are up to 10 times more concentrated than bone marrow stem cells. In … Continue reading →

Miami (PRWEB) May 31, 2014 Global Stem Cells Group and the Servet CordnVida Stem Cell Bank Clinic of Chile will be teaming up to organize the First International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 26, 27 and 28. The three-day symposium will be followed by an intensive hands-on training course at the Servet Clinic for medical practitioners interested in learning techniques for harvesting stem cells for in-office medical therapies. Symposium organizers plan to initiate a dialogue between researchers and practitioners to bridge the gap between bench scienceresearch science that is exclusively conducted in a lab settingand stem cell therapies delivered in the physicians office. The first-of-its-kind conference will host some of the worlds leading experts on stem cell research and therapies. Servet CordnVida General Manager Mauricio Cortes, Ph.D. says that Santiago is the perfect launching pad for the event, as awareness and increasing demand for stem cell services has swept the South American countrys healthcare market over the past decade. The use of human stem cells in medical therapies has attracted major scientific and public attention because stem cells are pluripotent, meaning they have the ability to differentiate into all body tissues, Cortes says. Knowing … Continue reading →

The gap between stem cell research and regenerative medicine just became a lot narrower, thanks to a new technique that coaxes stem cells, with potential to become any tissue type, to take the first step to specialization. It is the first time this critical step has been demonstrated in a laboratory. University of Illinois researchers, in collaboration with scientists at Notre Dame University and the Huazhong University of Science and Technology in China, published their results in the journal Nature Communications. "Everybody knows that for an embryo to form, somehow a single cell has a way to self-organize into multiple cells, but the in vivo microenvironment is not well understood," said study leader Ning Wang, a professor of mechanical science and engineering at the U. of I. "We want to know how they develop into organized structures and organs. It doesn't happen by random chance. There are biological rules that we don't yet understand." During fetal development, all the specialized tissues and organs of the body form out of a small ball of stem cells. First, the ball of generalized cells separates into three different cell lines, called germ layers, which will become different systems of the body. This crucial … Continue reading →

Rose Schwarz and her family will travel to Mexico next week to try some new treatments that will hopefully cure the Lyme disease that plagues the 74-pound woman. A successful online fundraiser for Schwarz brought in more than $23,000 last month, which opened up new options for treatment. Once the funds came in, Roses mom Tani Schwarz spent days researching online and talking to multiple doctors and patients before making the decision to head to Mexico for three weeks of alternative, complementary and integrative therapy at Baja MedGate in Baja Mexico. Treatment down there is way more state-of-the-art and modern than here, contrary to popular belief, Tani said. She and Rose will travel to Baja MedGate on June 6, when the therapy will start. The first two days will involve extensive specific testing and blood analysis, Tani said. Treatment will include IV delivery of specific detox, nutrition and immune support, essential fatty acid therapy, cocarboxilasa protocol, symphatic therapy, magnetic and ozone therapy, GcMAF therapy, high dose IV curcumin therapy and Mesenchymal stem cell therapy taken from donated adipose tissue. Rose will also receive bioidentical hormone replacement testing and treatment to help with her extremely low bone mass. While some of … Continue reading →

Nearly 1,650 people in the U.S. are awaiting lung transplants. Unfortunately, both domestically and abroad, the demand for donor lungs far outpaces the supply. The limited availability of donor lungs can lead to long delays before transplant, leaving patients to face a mortality rate of up to 40 percent while they wait. Most potentially transplantable lungs are rejected by surgical teams because of injury or dysfunction, such as pulmonary edema (fluid build-up in the lungs). In addition to rendering lungs unusable for transplant, pulmonary edema also signals that the lungs are not functioning properly post-transplant and is a major cause of illness and death among lung transplant recipients. Lungs that can clear fluid better are associated with better outcomes among recipients after transplantation. In this study, Danny F. McAuley, Gerard F. Curley, Umar I. Hamid, John G. Laffey, Jason Abbott, David H. McKenna, Xiaohui Fang, Michael A. Matthay, and Jae W. Lee looked at whether lungs that were rejected for transplantation because of edema could be "reconditioned" to qualify for transplant. They studied donor lungs that had been rejected for transplantation by the Northern California Transplant Donor Network and that were cleared for research use by the donors' families. Roughly … Continue reading →

PUBLIC RELEASE DATE: 28-May-2014 Contact: Robert Miranda cogcomm@aol.com Cell Transplantation Center of Excellence for Aging and Brain Repair Tampa, Fla. (May 28, 2014) To be suitable for medical transplantation, one idea is that human embryonic stem cells (hESCs) need to remain "undifferentiated" i.e. they are not changing into other cell types. In determining the best way to culture hESCs so that they remain undifferentiated and also grow, proliferate and survive, researchers have used blood cell "feeder-layer" cultures using animal-derived feeder cells, often from mice (mouse embryonic fibroblasts [MEFs]). This approach has, however, been associated with a variety of contamination problems, including pathogen and viral transmission. To avoid contamination problems, a Brazilian research team has investigated the use of human menstrual blood-derived mesenchymal cells (MBMCs) as feeder layers and found that "MBMCs can replace animal-derived feeder systems in human embryonic stem cell culture systems and support their growth in an undifferentiated stage." The study will be published in a future issue of Cell Medicine, but is currently freely available on-line as an unedited early e-pub at: http://www.ingentaconnect.com/content/cog/cm/pre-prints/content-CM1019silvadosSantos. "Human embryonic stem cells present a continuous proliferation in an undifferentiated state, resulting in an unlimited amount of cells with the potential to differentiate … Continue reading →

9 hours ago Researchers investigating the use of human menstrual blood-derived mesenchymal cells (MBMCs) as culture 'feeder layers' found that MBMCs can replace animal-derived feeder systems in human embryonic stem cell culture systems and support their undifferentiated growth, while helping the cells proliferate and survive. For medical transplantation, human embryonic stem cells (hESCs) may need to remain "undifferentiated" and the experimenter's technique preserves the undifferentiated nature of hESCs destined for transplantation and also prevents potential animal cell contamination. To be suitable for medical transplantation, one idea is that human embryonic stem cells (hESCs) need to remain "undifferentiated" i.e. they are not changing into other cell types. In determining the best way to culture hESCs so that they remain undifferentiated and also grow, proliferate and survive, researchers have used blood cell "feeder-layer" cultures using animal-derived feeder cells, often from mice (mouse embryonic fibroblasts [MEFs]). This approach has, however, been associated with a variety of contamination problems, including pathogen and viral transmission. To avoid contamination problems, a Brazilian research team has investigated the use of human menstrual blood-derived mesenchymal cells (MBMCs) as feeder layers and found that "MBMCs can replace animal-derived feeder systems in human embryonic stem cell culture systems and support … Continue reading →

The world has great expectations that stem cell research one day will revolutionize medicine. But in order to exploit the potential of stem cells, we need to understand how their development is regulated. Now researchers from University of Southern Denmark offer new insight. Stem cells are cells that are able to develop into different specialized cell types with specific functions in the body. In adult humans these cells play an important role in tissue regeneration. The potential to act as repair cells can be exploited for disease control of e.g. Parkinson's or diabetes, which are diseases caused by the death of specialized cells. By manipulating the stem cells, they can be directed to develop into various specialized cell types. This however, requires knowledge of the processes that regulate their development. Now Danish researchers from University of Southern Denmark report a new discovery that provides valuable insight into basic mechanisms of stem cell differentiation. The discovery could lead to new ways of making stem cells develop into exactly the type of cells that a physician may need for treating a disease. "We have discovered that proteins called transcription factors work together in a new and complex way to reprogram the DNA … Continue reading →

Arthritic knee 10 weeks after stem cell therapy by Dr Harry Adelson Frank describes his results for his stem cell therapy injection by Dr Harry Adelson for his arthritic knee http://www.docereclinics.com. By: Harry Adelson, N.D. … Continue reading →

May 22, 2014 The world has great expectations that stem cell research one day will revolutionize medicine. But in order to exploit the potential of stem cells, we need to understand how their development is regulated. Now researchers from University of Southern Denmark offer new insight. Stem cells are cells that are able to develop into different specialized cell types with specific functions in the body. In adult humans these cells play an important role in tissue regeneration. The potential to act as repair cells can be exploited for disease control of e.g. Parkinson's or diabetes, which are diseases caused by the death of specialized cells. By manipulating the stem cells, they can be directed to develop into various specialized cell types. This however, requires knowledge of the processes that regulate their development. Now Danish researchers from University of Southern Denmark report a new discovery that provides valuable insight into basic mechanisms of stem cell differentiation. The discovery could lead to new ways of making stem cells develop into exactly the type of cells that a physician may need for treating a disease. "We have discovered that proteins called transcription factors work together in a new and complex way to … Continue reading →